Award recordCONTRACT

MDD US OPERATIONS, LLC

PIID 36C26019N0097· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2019· $123,250 net obligations· UEI NKGSYBV5UGN1· KY

Description

APOKYN (APOMORPHINE HCL)

First action · last action
2018-10-01 · 2019-12-05
Transactions
2
First transaction's obligation
$157,836
Base + all options value (sum of deltas)
$123,250
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA797P15A0008
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$157,836$0Base award · 2018-10-01 · this action $157,836 · running total $157,836Modification P00001 · 2019-12-05 · this action -$34,586 · running total $123,250
  • Base2018-10-01+$157,836= $157,836
  • Mod P000012019-12-05-$34,586= $123,250
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-10-01+$157,836$157,836APOKYN (APOMORPHINE HCL)
Mod P00001· FUNDING ONLY ACTION2019-12-05−$34,586$123,250APOKYN (APOMORPHINE HCL)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI NKGSYBV5UGN1)

AwardOffice · PSC / listingNet obligationsFY
36C24718K0061247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$35,239FY2018
36C24918N4031249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$12,855FY2018
36C24918F3178249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$12,855FY2018
36C24918F2770249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$10,713FY2018
36C24718K0060247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$89,559FY2018
36C24918F2215249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$4,999FY2018

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26019N0097_3600_VA797P15A0008_3600 · retrieved 2026-09-26.